Cell-free DNA fetal risk assessment in routine prenatal care — a prospective multi-site study article readers will open to understand the study type and clinical relevance.
Key Takeaways
- Prospective study enrolled 2,212 pregnant carriers with unknown partner status across nine U.S
- Unity Fetal Risk Screen showed 94.4% sensitivity, 99.5% specificity, and >99.9% negative predictive value
- Outcome data were obtained for 98.6% of pregnancies completing care at participating sites